Pfizer (NYSE: PFE) reported Q2 EPS of $0.78, $0.21 better than the analyst estimate of $0.57. Revenue for the quarter came in at $14.7 billion versus the consensus estimate of $13.47 billion.

GUIDANCE:

Pfizer sees FY2025 EPS of $2.90-$3.10, versus the consensus of $3.01.

For earnings history and earnings-related data on Pfizer (PFE) click here.